Cannabidiol: What is CBD, how does it work, and what are the risks?
The European Medicines Agency (EMA) will rule on the drug early next year. If the EMA approves Epidiolex, it could be available to prescribe to named patients in Britain next year, Brexit notwithstanding. A review of completed and ongoing clinical trials indicated that adding CBD to common antiepileptic drugs may be appropriate in treatment-resistant epilepsy …
Cannabidiol: What is CBD, how does it work, and what are the risks? Read More »